Assenagon Asset Management S.A. Eli Lilly & CO Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,165,696 shares of LLY stock, worth $928 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares

1,165,696

Previous 580,830 100.69%

Holding current value

$928 Million

Previous $526 Million 96.39%

% of portfolio

2.16%

Previous 1.34%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $452 Million - $561 Million	584,866 Added 100.69%	1,165,696 $1.03 Billion
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $47 Million - $59 Million	64,869 Added 12.57%	580,830 $526 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $136 Million - $182 Million	229,319 Added 80.0%	515,961 $401 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $98.9 Million - $117 Million	-188,298 Reduced 39.65%	286,642 $167 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $7.86 Million - $10.8 Million	18,079 Added 3.96%	474,940 $255 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $112 Million - $149 Million	318,391 Added 229.94%	456,861 $214 Million
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $138 Million - $162 Million	-444,678 Reduced 76.25%	138,470 $47.6 Million
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $57.8 Million - $67.4 Million	179,865 Added 44.6%	583,148 $213 Million
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $92.2 Million - $105 Million	310,845 Added 336.27%	403,283 $130 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $9.19 Million - $10.8 Million	-32,983 Reduced 26.3%	92,438 $30 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $119 Million - $148 Million	-506,371 Reduced 80.15%	125,421 $35.9 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $75.5 Million - $93.7 Million	335,703 Added 113.38%	631,792 $175 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $27.1 Million - $33.3 Million	122,224 Added 70.3%	296,089 $68.4 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $41.6 Million - $53.8 Million	-230,251 Reduced 56.98%	173,865 $39.9 Million
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $3.18 Million - $4.11 Million	19,333 Added 5.02%	404,116 $75.5 Million
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $34.8 Million - $46 Million	266,505 Added 225.32%	384,783 $65 Million
Q3 2020 Oct 07, 2020	BUY	$146.22 - $169.13 $15.5 Million - $17.9 Million	105,706 Added 840.8%	118,278 $17.5 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $16.1 Million - $19.4 Million	-118,379 Reduced 90.4%	12,572 $2.06 Million
Q1 2020 Apr 17, 2020	BUY	$119.05 - $147.35 $13.5 Million - $16.7 Million	113,558 Added 652.89%	130,951 $18.2 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $43.6 Million - $54 Million	-407,473 Reduced 95.91%	17,393 $2.29 Million
Q3 2019 Oct 16, 2019	BUY	$106.79 - $116.16 $42.9 Million - $46.7 Million	401,683 Added 1732.66%	424,866 $47.5 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $90.1 Million - $105 Million	-813,478 Reduced 97.23%	23,183 $2.57 Million
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $15.7 Million - $18.5 Million	-141,343 Reduced 14.45%	836,661 $109 Million
Q4 2018 Jan 23, 2019	BUY	$105.9 - $118.64 $104 Million - $116 Million	978,004 New	978,004 $113 Million
Q4 2017 Jan 25, 2018	SELL	$81.94 - $87.89 $11.2 Million - $12 Million	-136,517 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $10.5 Million - $11.7 Million	136,517	136,517 $11.7 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Eli Lilly & CO Transaction History